Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgr...

Por Garrido, Pilar, Chouaki, Nadia, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Soldatenkova, Victoria, Novello, Silvia
Publicado no ESMO Open (2017)

Clinical value of early detection of circulating tumour DNA-BRAF(V600mut) in patients with metastatic melanoma treated with a BRAF inhibitor

Por Louveau, Baptiste, Tost, Jörg, Mauger, Florence, Sadoux, Aurélie, Podgorniak, Marie-Pierre, How-Kit, Alexandre, Pages, Cécile, Roux, Jennifer, Da Meda, Laetitia, Lebbe, Céleste, Mourah, Samia
Publicado no ESMO Open (2017)

New molecular and immunotherapeutic approaches in biliary cancer

Por Goldstein, David, Lemech, Charlotte, Valle, Juan
Publicado no ESMO Open (2017)

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

Por Preusser, Matthias, De Mattos-Arruda, Leticia, Thill, Marc, Criscitiello, Carmen, Bartsch, Rupert, Ruhstaller, Thomas, de Azambuja, Evandro, Zielinski, Christoph C
Publicado no ESMO Open (2018)

Upper tract urothelial carcinoma: a different disease entity in terms of management

Por Leow, Jeffrey J, Chong, Kian Tai, Chang, Steven L, Bellmunt, Joaquim
Publicado no ESMO Open (2017)

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Por Salvatore, Lisa, Aprile, Giuseppe, Arnoldi, Ermenegildo, Aschele, Carlo, Carnaghi, Carlo, Cosimelli, Maurizio, Maiello, Evaristo, Normanno, Nicola, Sciallero, Stefania, Valvo, Francesca, Beretta, Giordano D
Publicado no ESMO Open (2017)

Educational video: the role of PD-L1 in the local tumour microenvironment

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2017)

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

Por Tabernero, Josep, Vyas, Malvika, Giuliani, Rosa, Arnold, Dirk, Cardoso, Fatima, Casali, Paolo G, Cervantes, Andres, Eggermont, Alexander MM, Eniu, Alexandru, Jassem, Jacek, Pentheroudakis, George, Peters, Solange, Rauh, Stefan, Zielinski, Christoph C, Stahel, Rolf A, Voest, Emile, Douillard, Jean-Yves, McGregor, Keith, Ciardiello, Fortunato
Publicado no ESMO Open (2017)

Multiple primary tumours: challenges and approaches, a review

Por Vogt, Alexia, Schmid, Sabine, Heinimann, Karl, Frick, Harald, Herrmann, Christian, Cerny, Thomas, Omlin, Aurelius
Publicado no ESMO Open (2017)

Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

Por Kato, Ryoji, Hayashi, Hidetoshi, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado no ESMO Open (2017)

New treatment options for metastatic renal cell carcinoma

Por Rodriguez-Vida, Alejo, Hutson, Thomas E, Bellmunt, Joaquim, Strijbos, Michiel H
Publicado no ESMO Open (2017)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches

Por Economopoulou, Panagiota, Kotsantis, Ioannis, Psyrri, Amanda
Publicado no ESMO Open (2017)

Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?

Por Chua, Kevin LM, Kusumawidjaja, Grace, Murgic, Jure, Chua, Melvin LK
Publicado no ESMO Open (2017)

Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?

Por Salati, Massimiliano, Di Emidio, Katia, Tarantino, Vittoria, Cascinu, Stefano
Publicado no ESMO Open (2017)

Highlights for ESMO 40: celebration review for lifetime achievement awards

Por Saijo, Nagahiro
Publicado no ESMO Open (2016)

Drug development: successes, problems and pitfalls—the industry perspective

Por Wein, Wolfgang
Publicado no ESMO Open (2016)

Biosimilars

Por Martin, Miguel
Publicado no ESMO Open (2018)

In the literature: February 2018

Por Cervantes, Andrés
Publicado no ESMO Open (2018)

Hallmarks of glioblastoma: a systematic review

Por Nørøxe, Dorte Schou, Poulsen, Hans Skovgaard, Lassen, Ulrik
Publicado no ESMO Open (2017)

Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?

Por Cheung, Matthew C, Chan, Kelvin KW, Sabharwal, Mona, Fields, Anthony, Chambers, Alexandra, Evans, William K
Publicado no ESMO Open (2017)